BioSpace News Archive

New Drug Application for investigational product HP-3070 under FDA review

Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, announced that it will present a poster at the 2019 American Society of Clinical Oncology meeting, which is being held from May 31 to June 4, 2019, at the McCormick Place Convention Center in Chicago, Illinois.

Professor Sheila Ridner, PhD, RN, FAAN, the Martha Rivers Ingram Professor of Nursing at Vanderbilt University School of Nursing, Principal Investigator, PREVENT trial.

Hear from leading experts, including keynote speaker Gordon J. Christensen DDS, MSD, PhD, on the latest trends and innovations in dentistry [16-May-2019] IRVINE, Calif. , May 16, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, is proud to announce that it will host the Advancing Dentistry Symposium in San Diego, California

Lifestyle Delivery Systems Inc.,, is pleased to announce that during its fourth quarter of 2018 the Company generated over three million dollars in revenue, as reported in its Annual Audited Financial Statements filed on SEDAR.

New Data in Bladder Cancer Demonstrates Potential of Clinical Program for HER2 Cancers

Kelleher and Tourtellotte join ranks of unstoppable entrepreneurs in New England

Monarch Alternative Capital LP announced the successful completion of the previously announced acquisition of Shopko Optical.

Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr. William F. Feehery as its new Chief Executive Officer (CEO) and a member of the Certara Board of Directors, effective June 3, 2019.

Abiomed announces that the Impella CP with SmartAssist, which is designed to improve patient outcomes with advanced algorithms and simplified patient management, will be commercially available beginning at the 2019 Society for Cardiovascular Angiography & Interventions Scientific Sessions through a controlled launch process at select sites.